What is the long-term trend for Utah Medical Products's common stock, par value (in dollars per share)?

Over 5 years (2020 to 2025), Utah Medical Products's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.

Utah Medical Products UTMD Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Becton, Dickinson and CompanyBDX

——

The Cooper Companies, Inc.COO

——

IAR

Integra LifeSciencesIART

——

Pediatrix Medical GroupMD

——

UFP TechnologiesUFPT

——

InfuSystem HoldingsINFU

——

Other financials

Income statement

See full

Revenue$8.7M-10.2%

Gross profit$5.3M-4.6%

Operating income$2.6M-18.6%

Net income$2.6M-14.4%

EPS (diluted)$0.82-10.9%

Balance sheet

See full

Cash & equivalents$87.4M+4.9%

Total debt$210.0K—

Total equity$120.4M+2.8%

Total assets$124.4M+1.5%

Cash flow

See full

Operating cash flow$3.1M-30.4%

CapEx$130.0K-29.3%

Free cash flow$3.0M-30.4%

Valuation

See full

Market cap$219.63M+26.4%

Enterprise value$132.44M+42.5%

P/E20.3×+6.4×

P/S5.9×+1.4×

Profitability

See full

Gross margin57.9%-0.4pp

Operating margin28.8%-3.9pp

Net margin28.9%-4.1pp

FCF margin34.7%0.0pp

Returns & leverage

See full

Return on equity9.1%-1.4pp

Debt / equity0×—

Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Utah Medical Products's common stock, par value (in dollars per share)?: Utah Medical Products (UTMD) reported common stock, par value (in dollars per share) of $0.01 in Q1 2026.
How has Utah Medical Products's common stock, par value (in dollars per share) changed year-over-year?: Utah Medical Products's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0.01 to $0.01.
What is the long-term trend for Utah Medical Products's common stock, par value (in dollars per share)?: Over 5 years (2020 to 2025), Utah Medical Products's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.